For the first time, we have demonstrated that expression of this membrane-associated MMP inhibitor is regulated by TGF-β1 in a breast cancer cell culture model, suggesting that RECK could be involved in the molecular mechanisms of breast cancer progression. The gene discussed is TGFB1; the disease is breast cancer.